AMPIO PHARMACEUTIC.DL-,01
stock DE:APH (FRANKFURT)

Alternative ID: US03209T1097

Watch List

Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!
  • Exchange: FRANKFURT
  • Sector: Healthcare
  • Industry: Biotechnology
  • Market Cap: Nano (10.38M)
  • Data in EUR
  • EPS: -0.08
  • Current PE: -1,020.66
  • BVPS: 0.07
  • Price/BVPS: 1,108.14
  • Hist Grade: F (0.00)
  • YOY Grade: F (0.00)
  • Debt/FCF: -0.09
  • ROIC: -72.8%
  • PEG:
  • PEGY:
  • Value Price: 0.00
  • MOS Price: 0.00
  • MOS %: -100.0%
  • Graham Number: 0.00
  • Graham MOS %: -100.0%
  • IRT: 99.00

Market Price

77.57 

1.75 2.3%

as of Jun 02 '23

52 Week Range:

0.05 82.86

Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

  • Exchange: FRANKFURT
  • Sector: Healthcare
  • Industry: Biotechnology
  • Market Cap: Nano (10.38M)
  • Inst. Ownership: 13.76%
  • Insider Ownership: 7.51%
  • Full Time Employees: 18
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement


 

Cash Flow Statement


 

Balance Sheet


 

Liquidity Ratios

Current Ratio

 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio

 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage

 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA

 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE

 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC

 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) 0.66
1.16
0.79
0.16
0.02
0.02
0.05
0.07
growth rate 75.8% -31.9% -79.8% -64.6% 0.0% 150.0% 40.0%
Earnings BIT -31.45
-24.17
-17.08
-15.68
-11.18
-18.58
-15.83
-20.57
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Avg.PE -1.86
-4.43
-4.43
-4.43
-4.43
-4.43
growth rate 0.0% 0.0% 0.0% 0.0% 0.0%
ROA -181.59
-51.15
-77.61
-71.74
-53.05
-59.87
-358.98
231.63
-97.25
-86.20
-55.35
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% -100.0% 0.0% 0.0%
ROE -267.02
-55.75
-84.38
-76.87
-62.09
-87.84
-233.41
-132.70
-76.23
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
ROIC -267.00
-55.85
-84.42
-76.91
-56.68
-87.95
-186.49
-119.45
-72.79
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cur. Ratio 8.83
10.91
10.69
13.93
5.30
2.53
2.18
5.78
1.93
10.08
6.96
growth rate 23.6% -2.0% 30.3% -62.0% -52.3% -13.8% 165.1% -66.6% 422.3% -31.0%
Quick Ratio 8.80
10.81
10.64
13.67
4.88
2.35
2.12
5.48
1.52
9.56
6.62
growth rate 22.8% -1.6% 28.5% -64.3% -51.8% -9.8% 158.5% -72.3% 529.0% -30.8%
Leverage 1.09
1.08
1.09
1.06
1.36
2.05
2.68
2.17
1.31
1.42
growth rate -0.9% 0.9% -2.8% 28.3% 50.7% 14.3% -19.0% -39.6% 8.4%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 0.04
0.02
0.19
0.02
growth rate -17.3% 927.8% -91.4%
Acct.Payable 3.30
1.80
0.71
2.79
0.71
0.15
0.19
0.43
growth rate -45.3% -60.7% 292.7% -74.7% -78.6% 23.2% 129.6%
Cur.Assets 51.26
29.23
5.40
8.44
8.03
8.25
18.49
35.63
growth rate -43.0% -81.5% 56.3% -4.9% 2.7% 124.2% 92.7%
Total Assets 70.27
50.42
13.60
15.31
14.03
14.00
22.88
38.83
growth rate -28.3% -73.0% 12.6% -8.4% -0.2% 63.4% 69.7%
Cash 50.32
16.00
4.89
8.21
7.59
6.53
17.35
33.89
growth rate -68.2% -69.4% 67.7% -7.6% -13.9% 165.6% 95.4%
Inventory 0.07
growth rate
Cur.Liabilities 3.68
5.52
2.13
3.88
1.38
4.28
1.83
5.12
growth rate 49.9% -61.3% 81.7% -64.3% 209.5% -57.2% 179.3%
Liabilities 4.81
12.49
6.96
49.49
8.79
7.56
5.37
11.54
growth rate 159.7% -44.3% 610.9% -82.2% -14.1% -29.0% 115.1%
LT Debt 4.24
45.08
growth rate 963.5%
Equity 66.12
37.00
6.63
-34.18
5.24
6.44
17.51
27.28
growth rate -44.0% -82.1% -100.0% 100.0% 23.1% 171.8% 55.8%
Common Shares 26.00
34.00
38.00
50.00
52.00
54.00
65.00
0.01
0.02
0.02
0.02
growth rate 30.8% 11.8% 31.6% 4.0% 3.9% 20.4% -100.0% 45.5% 18.8% 21.1%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 8.67
0.11
0.01
0.07
0.56
0.02
0.06
0.10
growth rate -98.7% -93.9% 963.2% 680.1% -96.1% 186.4% 54.0%
Cash From OA -30.74
-26.44
-14.63
-11.41
-12.14
-15.38
-14.73
-14.09
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF per Share -0.34
-0.67
-0.45
-0.36
-0.16
-0.13
-0.11
-0.08
-0.06
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sale Purchase of Stock 68.41
0.03
3.90
14.79
growth rate -100.0% 13,453.1% 279.0%
FCF -9.00
-10.00
-21.00
-39.00
-27.00
-15.00
-11.00
-13.00
-15.00
-15.00
-14.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Op.Income -31.45
-24.17
-17.08
-15.68
-11.18
-18.58
-15.83
-20.57
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
IBT -31.31
-24.11
-19.16
-51.89
33.99
-13.63
-15.89
-17.08
growth rate 0.0% 0.0% 0.0% 100.0% -100.0% 0.0% 0.0%
Net Income -38.13
-32.01
-19.16
-51.89
33.99
-13.63
-15.89
-17.08
growth rate 0.0% 0.0% 0.0% 100.0% -100.0% 0.0% 0.0%
EPS -0.71
-0.34
-0.63
-0.76
-0.62
-0.36
-0.79
0.46
-0.14
-0.09
-0.10
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% -100.0% 0.0% 0.0%
R&D 22.49
15.11
10.55
10.42
6.83
12.62
9.17
11.90
growth rate -32.8% -30.2% -1.2% -34.5% 84.8% -27.3% 29.7%

Quarterly Statements

Item Name Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Earnings BIT -3.67
-3.85
-9.23
-6.97
-4.99
growth rate 0.0% 0.0% 0.0% 0.0%
Balance Sheet Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Acct.Receivable 0.03
0.05
0.02
0.02
growth rate 50.0% -64.4% 18.8%
Acct.Payable 0.17
0.31
0.43
1.58
0.72
growth rate 80.6% 39.1% 270.5% -54.6%
Cur.Assets 22.91
18.97
35.63
29.91
24.64
growth rate -17.2% 87.9% -16.1% -17.6%
Total Assets 26.71
22.47
38.83
32.79
27.22
growth rate -15.9% 72.8% -15.6% -17.0%
Cash 20.55
17.12
33.89
28.84
22.89
growth rate -16.7% 98.0% -14.9% -20.6%
Inventory 0.07
growth rate
Cur.Liabilities 3.24
2.39
5.12
5.53
5.08
growth rate -26.2% 114.6% 7.9% -8.0%
Liabilities 6.35
5.20
11.54
10.53
7.12
growth rate -18.1% 122.0% -8.7% -32.4%
LT Debt
growth rate
Equity 20.36
17.28
27.28
22.25
20.10
growth rate -15.2% 57.9% -18.4% -9.7%
Common Shares 0.02
0.02
0.02
0.02
0.02
growth rate 0.0% 15.0% 0.0% 0.0%
Cash Flow Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Capital Expenditures 0.02
0.02
growth rate 0.0%
Cash From OA -2.33
-3.91
-3.70
-4.94
-5.95
growth rate 0.0% 0.0% 0.0% 0.0%
Sale Purchase of Stock
growth rate
FCF -2.34
-3.93
growth rate 0.0%
Income Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Op.Income -3.67
-3.85
-9.23
-6.97
-4.99
growth rate 0.0% 0.0% 0.0% 0.0%
IBT -3.56
-3.63
-6.22
-5.64
-2.07
growth rate 0.0% 0.0% 0.0% 0.0%
Net Income -3.56
-3.63
-6.22
-5.64
-2.07
growth rate 0.0% 0.0% 0.0% 0.0%
R&D 2.27
2.59
4.74
3.69
1.74
growth rate 14.1% 82.6% -22.2% -52.7%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

F (0.00)

Click on buttons above for detailed yearly growth rates.

Market Ratios

  • Dividend Yield:

  • Beta: 1.84

    Beta of 1.8427 suggests that the asset is more volatile than the rest of the market.

  • PE: -1,020.66

  • EY: -0.1%

  • PEG:

    PEG Ratio of suggests that

  • PEGY:

    PEGY Ratio of suggests that

  • Price/BVPS: 1,108.14

Profitability Ratios

  • ROE: -76.2%

    Return on Equity (ROE) of -76.2% suggests that a company may not be able to fund future growth from within.

  • ROS:

    The value of Return on Sales depends on the business and/or industry. Usually the higher ratio the better.

  • ROA: -44.0%

    Return on Assets (ROA). Low ratio usually means poor performance, or ineffective use of assets by management. High ratio usually means good performance.

  • ROI: -62.6%

    Return on Investment (ROI) of -62.6% suggests that a company may not be able to fund future growth from within.

  • ROIC: -72.8%

    Return on Invested Capital (ROIC) of -72.8% suggests that a company may not be able to fund future growth from within.

Liquidity Ratios

  • Current Ratio: 6.96

    Current Ratio of 6.96 suggests that money that could be working for the business is tied up in government securities, cash savings or other safe funds.

  • Quick Ratio: 6.62

    Quick Ratio of 6.62 suggests that a company is doing well.

  • Cash Turnover:

  • Equity Ratio: 70.3%

    Equity Ratio of 70.3% suggests that a large percent of the company's assets financed by shareholder equity, which is good.

  • Debt/Equity: 42.3%

    Debt to Equity Ratio of 42.3% suggests that a company is doing well.

  • Debt/FCF: -0.09

    Debt/FCF of -0.09 suggests that a company has a negative Free Cash Flow and probably will not be able to pay off its long term debt.

Efficiency Ratios

  • Avg Collection Period:

  • Inventory Turnover:

  • Cash Flow Ratio: 0.21

    Cash Flow Ratio of 0.21 suggests that a company is managing it's inventory efficiently.

  • Profit Margin:

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE -4.43 -1,020.66 -0.65
EPS / Growth -0.08

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 50.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 40.0% 50.0% 50.1%
Future PE 0.01 0.01 33.42
Future EPS 0.00 0.00 0.00
Value Price
MOS %		 0.00
-100.0% 		0.00
-100.0% 		0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

  • Graham Number: 0.00
  • Graham MOS: -100.0%

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.